483 Zhejiang Huazhou Pharmaceutical Mar 2018

483 Zhejiang Huazhou Pharmaceutical Mar 2018

Christopher Middendorf FDA$119.00 - Available Now

FDA investigators audited the Zhejiang Huazhou Pharmaceutical - Taizhou, China facility and issued inspectional observations (via FDA 483) on 22 Mar 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 22 Mar 2018
  • Location: Taizhou, China
  • FEI: 3012672996
Add To Cart